Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait.


Journal

Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 25 01 2021
revised: 05 03 2021
accepted: 07 03 2021
pubmed: 14 3 2021
medline: 27 11 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

Eleven metronidazole resistant Bacteroides and one newly classified Phocaeicola dorei strain from Kuwait were investigated for their resistance mechanisms and the emergence of their resistant plasmids. All but one strain harbored nimE genes on differently sized plasmids. Of the 11 nimE genes, 9 were preceded by full copies of the prototype ISBf6 insertion sequence element, one carried a truncated ISBf6 and one was activated by an additional copy of IS612B. Nucleotide sequencing results showed that the nimE ISBf6 distances were constant and all five different plasmids shared a common region, suggesting that (i) the nimE-ISBf6 configuration was inserted into an undisclosed common genetic element, (ii) over time, this common element was mutated by insertions and deletions, spreading the resultant plasmids. Of the 10 B. fragilis strains in this collection, 6 were also cfiA-positive, one with full imipenem resistance, indicating a tendency for multidrug resistance (MDR) among such isolates. The significant number of metronidazole resistant Bacteroides spp. and P. dorei strains with the MDR phenotype warns of difficulties in treatment and suggests promoting adherence to antibiotic stewardship recommendations in Kuwait.

Identifiants

pubmed: 33713801
pii: S1075-9964(21)00040-8
doi: 10.1016/j.anaerobe.2021.102357
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Metronidazole 140QMO216E

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102357

Subventions

Organisme : Austrian Science Fund FWF
ID : I 4234
Pays : Austria

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We declare no conflict of interests.

Auteurs

Zain Baaity (Z)

Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Szeged, Hungary.

Wafaa Jamal (W)

Department of Microbiology, Faculty of Medicine, University of Kuwait, Safat, Kuwait.

Vincent O Rotimi (VO)

Department of Microbiology, Faculty of Medicine, University of Kuwait, Safat, Kuwait.

Katalin Burián (K)

Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Szeged, Hungary.

David Leitsch (D)

Institute for Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Ferenc Somogyvári (F)

Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Szeged, Hungary.

Elisabeth Nagy (E)

Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary.

József Sóki (J)

Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary. Electronic address: soki.jozsef@med.u-szeged.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH